Oncology Diagnostics

Scientific Description

Leverages molecular profiling to identify genetic and epigenetic alterations in cancer. Cancer Panels detect hereditary (e.g., BRCA1/2) and somatic mutations, while OncoMaster.AI uses AI-driven analytics to predict drug responses in colorectal cancer by assessing tumor mutational burden (TMB) and microsatellite instability (MSI). Tumor-informed ctDNA assays monitor minimal residual disease (MRD) via liquid biopsies, offering real-time insights into treatment efficacy and recurrence risk.

make an inquiry

Happy Patients

What Our Clients Say About Us

"Frankly speaking, the experience was the first time I dealt with them. They were very quick to respond. They made an appointment for me at home on their appointment, and there was no delay. The result was not delayed exactly as they said, 7 days. God willing, I wish them success, Lord."

Wejdan Sunbol

"I had a NIPT basic test last week and the results came out in less than a week. Their treatment in the laboratory was very elegant and the staff were professional. They were all cooperative and ready to answer all questions."

Saba Altalhi

"I had a genetic test done by them, one of the best, finest, and cleanest clinics. They were very cooperative with many questions I asked, but they were answering and appreciative. May God make them happy. The results came out before the due date. Thank you for all this kindness ."

Doua Alghamdi